Morinobu Seki
Morinobu Seki publishes mostly in Neurology, Psychiatry and Mental health and Physiology, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Alzheimer's disease research and treatments.
- World rank
- #1,312,688 of 7,710,434 ranked researchers
- Rank in Japan
- #19,716 of 383,136
- Works
- 85
- Citations
- 1.8k
- Citations per work
- 20.9
What does Morinobu Seki research?
Morinobu Seki's work is mostly in Medicine (64%), Neuroscience (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5564.3%
- Medicine5564.3%
- Everything else2630.5%
- Life Sciences45.2%
- Neuroscience45.2%
- 1Neurology40% of their works
- 2Psychiatry and Mental health7% of their works
- 3Physiology7% of their works
- 4Cellular and Molecular Neuroscience5% of their works
- 5Oncology5% of their works
- 6Epidemiology4% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Parkinson's Disease and Spinal Disorders
- Autoimmune Neurological Disorders and Treatments
- Genetic Neurodegenerative Diseases
- Botulinum Toxin and Related Neurological Disorders
Which keywords describe Morinobu Seki's research?
The keywords of their largest research topics: Parkinson's Disease, Neurological Disorders, Neurodegeneration, Oxidative Stress, Diagnostic Criteria, Mitochondrial Dysfunction, a-Synuclein and Dopaminergic Neurons.
- Botulinum Toxin
- Huntington's Disease
- Anti-NMDA Receptor Encephalitis
- Camptocormia
- Mild Cognitive Impairment
- Alzheimer's Disease
- Basal Ganglia
- a-Synuclein
- Mitochondrial Dysfunction
- Oxidative Stress
- Neurological Disorders
- Parkinson's Disease
- Neurodegeneration
- Diagnostic Criteria
- Dopaminergic Neurons
- Deep Brain Stimulation
- Subthalamic Nucleus
- Amyloid Hypothesis
- Tau Pathology
- Dropped Head Syndrome
- Paraneoplastic Syndromes
- Protein Aggregation
- Neurotoxins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Parkinson's Disease593 topics
- Neurological Disorders454 topics
- Neurodegeneration442 topics
- Oxidative Stress442 topics
- Diagnostic Criteria412 topics
- Mitochondrial Dysfunction402 topics
- Dopaminergic Neurons311 topic
- a-Synuclein311 topic
- Deep Brain Stimulation282 topics
- Basal Ganglia171 topic
- Subthalamic Nucleus171 topic
- Alzheimer's Disease131 topic
- Amyloid Hypothesis131 topic
- Mild Cognitive Impairment131 topic
- Tau Pathology131 topic
- Camptocormia111 topic
- Dropped Head Syndrome111 topic
- Anti-NMDA Receptor Encephalitis101 topic
- Paraneoplastic Syndromes101 topic
- Huntington's Disease91 topic
- Protein Aggregation91 topic
- Botulinum Toxin71 topic
- Neurotoxins71 topic
Where does Morinobu Seki work?
Morinobu Seki's main affiliation in the publication record is Keio University, Japan.
How many publications and citations does Morinobu Seki have?
OpenAlex counts 85 works and 1,773 citations for Morinobu Seki, an h-index of 21, ranking #1,312,688 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Morinobu Seki. Posts are plain text and can be reported.